SavedAdd your journal

Journals / Düzce Tıp Fakültesi Dergisi / 2012 / Cilt: 14 - Sayı: 3

Epigenetic Mechanisms and Cancer

Epigenetik Mekanizmalar ve Kanser

Ömer Faruk HATİPOĞLU
Ertuğrul KAYA
Emine YAYKAŞLI
Kürşat Oğuz YAYKAŞLI
Pages
58–68
Publication Date
2012-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review we summarize the information inliterature related with epigenetic mechanisms and their relationship with cancer

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epigenetics, proposed by Condrad Hal Waddington at the begining of the 1940 describesheritable changes that affect gene expression without changing DNA sequencing.
📊
Key Findings & Data:Afterresearches, it has been found that the epigenetics modifications perform important task in manybiological processes and diseases like cancer.
💡
Conclusion & Impact:In this review we summarize the information inliterature related with epigenetic mechanisms and their relationship with cancer
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Epigenetik mekanizmaler · Kanser · Kanser tedavisi

Abstract

Epigenetics, proposed by Condrad Hal Waddington at the begining of the 1940 describesheritable changes that affect gene expression without changing DNA sequencing. Afterresearches, it has been found that the epigenetics modifications perform important task in manybiological processes and diseases like cancer. In this review we summarize the information inliterature related with epigenetic mechanisms and their relationship with cancer

Özet

İlk defa 1940’ların başında Condrad Hal Waddington tarafından ortaya atılan epigenetikkavramı, DNA dizilimini değiştirmeden gen ifadesini etkileyen kalıtılabilir değişiklikler olaraktanımlanabilir. Yapılan araştırmalarla epigenetik mekanizmaların birçok biyolojik olayda vekanser gibi hastalıklarda önemli görevler ifa ettiği bulunmuştur. Bu derlemede literatürdekiepigenetik mekanizmalar ve bunların kanserle olan ilişkileri hakkında bilgiler özetlenmiştir

🔖

Cite This Article

HATİPOĞLU, Ö. F., KAYA, E., YAYKAŞLI, E., YAYKAŞLI, K. O. (2012). Epigenetic Mechanisms and Cancer. Düzce Tıp Fakültesi Dergisi, Cilt: 14 - Sayı: 3, 58–68. https://ajindex.com/articles/420713

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Jackson SP, Bartek J. The DNA-damage response in human biology and disease, Nature 2009; 461(7267):1071-8.
  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics, CA Cancer J Clin 2011; 61(2):69-90.
  3. Podlaha O, Riester M, De S, Michor F. Evolution of the cancer genome, Trends Genet 2012; 28(4):155-63.
  4. You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012; 22(1):9-20.
  5. Chervona Y, Costa M. Histone modifications and cancer: biomarkers of prognosis, Am J Cancer Res. 2012; 2(5):589- 97. Pogribny IP, Rusyn I. Environmental toxicants, epigenetics, and cancer, Adv Exp Med Biol. 2013; 754:215-32. Holwerda S, de Laat W. Chromatin loops, gene positioning, and gene expression, Front Genet. 2012; 3:217. Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy, Cell 2012; 150(1):12-27.
  6. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer, Carcinogenesis 2010; 31(1):27-36. Rando OJ. Combinatorial complexity in chromatin structure and function: revisiting the histone code, Curr Opin Genet Dev 2012; 22(2):148-55. Waddington,C.H. The epigenotype. 1942, Int J Epidemiol 2012; 41(1):10-3.
  7. Hassler MR, Egger G. Epigenomics of cancer - emerging new concepts. Biochimie 2012 (Epub ahead of print). Gerhauser C. Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges, Top Curr Chem 2012 [Epub ahead of print] Martín-Subero JI. How epigenomics brings phenotype into being, Pediatr Endocrinol Rev 2011; 9 Suppl 1:506-10.
  8. Sandoval J, Esteller M. Cancer epigenomics: beyond genomics, Curr Opin Genet Dev 2012; 22(1):50-5.
  9. Lansdorp PM, Falconer E, Tao J, Brind'amour J, Naumann U. Epigenetic differences between sister chromatids? Ann N Y Acad Sci 2012; 1266(1):1-6.
  10. Carone DM, Lawrence JB. Heterochromatin instability in cancer: From the Barr body to satellites and the nuclear periphery, Semin Cancer Biol 2012 [Epub ahead of print] Hatziapostolou M, Iliopoulos D. Epigenetic aberrations during oncogenesis, Cell Mol Life Sci 2011; 68(10):1681-702.
  11. Chin SP, Dickinson JL, Holloway AF. Clin Epigenetics. Epigenetic regulation of prostate cancer, 2011; 2(2):151-69.
  12. Catalano MG, Fortunati N, Boccuzzi G. Epigenetics modifications and therapeutic prospects in human thyroid cancer, Front Endocrinol (Lausanne) 2012; 3:40. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer, Epigenomics 2012; 4(3):279-94.
  13. Dubuc AM, Mack S, Unterberger A, Northcott